HighMark Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HighMark Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35K	Hold	221	–	–	0.01%	202
2026 Q1	$28.2K	Hold	221	–	–	0.01%	203
2025 Q4	$27K	Buy	221 +1	+0.5%	+$115	0.01%	219
2025 Q3	$22.1K	Hold	220	–	–	0.01%	227
2025 Q2	$18.3K	Hold	220	–	–	0.01%	234
2025 Q1	$17.9K	Sell	220 -1,404	-86%	-$125K	0.01%	206
2024 Q4	$146K	Sell	1,624 -599	-27%	-$58K	0.08%	69
2024 Q3	$220K	Hold	2,223	–	–	0.12%	61
2024 Q2	$206K	Buy	2,223 +3	+0.1%	+$269	0.12%	61
2024 Q1	$211K	Hold	2,220	–	–	0.13%	58
2023 Q4	$198K	Sell	2,220 -25	-1%	-$1.86K	0.15%	55
2023 Q3	$164K	Hold	2,245	–	–	0.14%	50
2023 Q2	$187K	Hold	2,245	–	–	0.14%	51
2023 Q1	$171K	Hold	2,245	–	–	0.13%	61
2022 Q4	$186K	Hold	2,245	–	–	0.14%	50
2022 Q3	$178K	Hold	2,245	–	–	0.15%	51
2022 Q2	$167K	Sell	2,245 -575	-20%	-$43.2K	0.13%	50
2022 Q1	$253K	Hold	2,820	–	–	0.17%	44
2021 Q4	$316K	Buy	2,820 +2,575	+1,051%	+$311K	0.2%	41
2021 Q3	$31K	Buy	+245	New	+$31.6K	0.02%	146

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

HighMark Wealth Management's XBI Position: Q2 2026 in Review

HighMark Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 221 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #202.

HighMark Wealth Management first reported a position in XBI in Q3 2021 and has held it in 20 quarters since. The position peaked at $316K in Q4 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

HighMark Wealth Management held 221 shares of State Street SPDR S&P Biotech ETF worth $35K as of Q2 2026.
HighMark Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #202 holding.
HighMark Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and has held it in 20 quarters since.
HighMark Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $316K in Q4 2021.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.